Status:

COMPLETED

PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Diabetes

Obesity

Eligibility:

All Genders

25-45 years

Brief Summary

The purpose of this research study is to use a relatively new technology, called Positron Emission Tomography (PET), to study how insulin works on sugar in your body's fatty tissue. PET imaging is a w...

Detailed Description

The association of adiposity with insulin resistance (IR) is modulated by regional fat deposition. For example, visceral (intra-abdominal) adipose tissue (VAT) is generally regarded as more strongly c...

Eligibility Criteria

Inclusion

  • A thorough medical examination will be done at the screening examination. To be eligible for these studies, volunteers must be free of clinical evidence of cardiac, renal, hepatic, and vascular disease, or other major medical problems that would endanger the volunteers or compromise the scientific validity of the studies.
  • We will recruit 20 volunteers (10 men and 10 women), non-obese (BMI 20 to 27 kg/m2), glucose tolerant, healthy volunteers, who are between the ages of 25 and 45 years old. Volunteers for this study must have a fasting glucose \< 100 mg/dl; HbA1c \< 5.7%; Hct \> 34; fasting plasma insulin level \< 12 µU/ml; ALT \< 60; AST \< 60; Alk phos \< 150; TSH \< 6; Trig \< 150 mg/dl; Chol \< 250; systolic BP \< 140; diastolic BP \< 90; negative family history (first-degree relatives) for type 2 DM; be in good health and not be taking any chronic medications known to affect adipose tissue metabolism or insulin sensitivity (e.g. glucocorticoids, thiazide diuretics).

Exclusion

  • Pregnant women and women who are currently breast-feeding will be excluded from study participation. Women will be checked for pregnancy (using a urine pregnancy test) at screening, within 24 hours prior to the DEXA scan and within 24 hours prior to each PET and MRI study. Previous difficulty with xylocaine or claustrophobia will exclude.

Key Trial Info

Start Date :

April 1 2005

Trial Type :

OBSERVATIONAL

End Date :

December 1 2006

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00222768

Start Date

April 1 2005

End Date

December 1 2006

Last Update

February 18 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213